5, 10, 15, 20-tetrakis (1-methylpyridinium-4-yl) porphyrin (tmpyp4) (CEM Corporation)
Structured Review

5, 10, 15, 20 Tetrakis (1 Methylpyridinium 4 Yl) Porphyrin (Tmpyp4), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmpyp4/g+quadruplex++tmpyp4/pmc06222717-19-52-21
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy"
Article Title: Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy
Journal: Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
doi: 10.3390/molecules23102628
Figure Legend Snippet: Targeting moiety approaches used to enhance NP PSs active drug delivery systems in tumours.
Techniques Used: Over Expression, In Vitro, In Vivo, Inhibition, Irradiation
Related Articles
other:Article Title: Self-assembly of a bifunctional DNA carrier for drug delivery. Article Snippet: Herein, we propose a simple method for combining two functional DNA groups, such that one group is capable of recognizing the target cell, while a complementary group acts as a drug delivery carrier.. This novel G-quadruplex–aptamer– drug platform takes advantage of the target-recognition function of a DNA aptamer and the drug-loading ability of a G-quadruplex.. The design and engineering are based on DNA selfassembly. Article Title: Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy Article Snippet: DNA G-quadruplex Aptamer , Direct , Sgc8 leukemia aptamer, which can specifically bind to Article Title: Targeted bioimaging and photodynamic therapy nanoplatform using an aptamer-guided G-quadruplex DNA carrier and near-infrared light. Article Snippet: Photodynamic therapy (PDT) has recently emerged as an effective, noninvasive, and economical treatment for diseases including cancers.. Traditional PDT suffers mainly from having an insufficient number of photons penetrating the tissue and preferentially targeting cancerous tissues with photosensitizers.. Therefore, it is necessary to construct a method for controllable singlet-oxygen (O2) generation (SOG) with high selectivity and accurate localization to provide more efficient PDT with fewer side effects. In Vitro:Article Title: Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures. Article Snippet: Due to the limitations of conventional cancer treatment methods, nanomedicine has appeared as a promising alternative, allowing improved drug targeting and decreased drug toxicity.. In the development of cancer nanomedicines, among various nanoparticles (NPs), DNA nanostructures are more attractive because of their precisely controllable size, shape, excellent biocompatibility, programmability, biodegradability, and facile functionalization.. Aptamers are introduced as single-stranded RNA or DNA molecules with recognize their corresponding targets. Control:Article Title: Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures. Article Snippet: Due to the limitations of conventional cancer treatment methods, nanomedicine has appeared as a promising alternative, allowing improved drug targeting and decreased drug toxicity.. In the development of cancer nanomedicines, among various nanoparticles (NPs), DNA nanostructures are more attractive because of their precisely controllable size, shape, excellent biocompatibility, programmability, biodegradability, and facile functionalization.. Aptamers are introduced as single-stranded RNA or DNA molecules with recognize their corresponding targets. Irradiation:Article Title: Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures. Article Snippet: Due to the limitations of conventional cancer treatment methods, nanomedicine has appeared as a promising alternative, allowing improved drug targeting and decreased drug toxicity.. In the development of cancer nanomedicines, among various nanoparticles (NPs), DNA nanostructures are more attractive because of their precisely controllable size, shape, excellent biocompatibility, programmability, biodegradability, and facile functionalization.. Aptamers are introduced as single-stranded RNA or DNA molecules with recognize their corresponding targets. |


